Alex W.

Alex W. is a highly accomplished business development professional and scientist with over a decade of experience in the biotechnology and pharmaceutical industry. With a background in biochemistry and molecular and cellular biology, Alex has established expertise in technology assessment, licensing, opportunity evaluation, research strategies, venture capital investments, project management, strategic partnerships, and cancer genomics research.

Education-wise, Alex pursued a Bachelor’s Degree in Biochemistry from the University of Victoria, a Doctor of Philosophy (Ph.D.) in Molecular and Cellular Biology from the University of Calgary, and a Master’s Degree in Biochemistry from Queen's University.

Throughout a rich and diverse career, Alex has held various significant roles, including serving as a Strategic Consultant at Lifescience Business Development Consultant, an Advisor at SeruCell, a Biology Teacher at Mason Academy, an Adjunct Professor at Bristol University, Director of Technology Assessment at Allergan, Consultant at FinTech Global Capital, Director of Research Planning at Daiichi Sankyo Pharma Research Institute, Scientist II at Myriad Genetics, and a Research Fellow at Harvard University.

An analytical and strategic leader, Alex W. excels in aligning colleagues and clients towards achieving ambitious goals in the biotechnology and pharmaceutical sectors.